Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.55
0.01 (2.38%)
At close: Aug 22, 2025, 3:59 PM
0.51
-6.59%
After-hours: Aug 22, 2025, 07:57 PM EDT

Aspire Biopharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-799.89K -15.56M -640.51K -242.62K -96.92K -163.87K -76.3K -65.53K -90.27K
Interest Income
n/a n/a 548.68K 76.75K 169.91K -246.66K 260.67K 255.48K n/a
Pretax Income
-1.98M -15.94M -738.5K -242.62K -96.92K -163.87K -76.3K -65.53K -90.27K
Net Income
-1.98M -15.94M -11.97M -243.63K -96.92K -163.87K -76.78K -65.53K -90.27K
Selling & General & Admin
447K 15.29M 2.55M 235.62K 86.42K 220.47K 65.8K 50.76K 79.77K
Research & Development
352.89K 263.09K 116.36K 7K 10.5K 10.5K 10.5K 14.78K 10.5K
Other Expenses
n/a n/a -77.41K n/a n/a -67.1K n/a n/a n/a
Operating Expenses
799.89K 15.56M 2.59M 242.62K 96.92K 163.87K 76.3K 65.53K 90.27K
Interest Expense
527.89K 289.93K 891.62K 8.5K 208.18K 183.31K 8.97K n/a n/a
Selling & Marketing Expenses
51.31K 219.84K -104.34K 16.68K 5K 87.67K 28.64K n/a 11K
Cost & Expenses
799.89K 15.56M 2.59M 242.62K 96.92K 163.87K 76.3K 65.53K 90.27K
Income Tax Expense
n/a n/a -1.01K 1.01K n/a n/a 481.00 n/a n/a
Shares Outstanding (Basic)
49.33M 7.77M 7.77M 45.94M 45.94M 45.94M 45.94M 45.94M 45.94M
Shares Outstanding (Diluted)
49.33M 7.77M 7.77M 45.94M 45.94M 45.94M 45.94M 45.94M 45.94M
EPS (Basic)
-0.04 -2.05 -1.15 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00
EPS (Diluted)
-0.04 -2.05 -1.15 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00
EBITDA
-1.45M -15.65M -8.64M -242.62K -96.92K n/a -76.3K -65.53K -90.27K
EBIT
-1.45M -15.65M -11.08M -242.62K -96.92K -163.87K -76.3K -65.53K -90.27K
Depreciation & Amortization
n/a n/a 2.44M n/a n/a 163.87K n/a n/a n/a